Trainee Track Webinar Thursday, April 6, 2017
Trainee Track Webinar
Transplantation and Private Practice: A Career Alternative and its Impact on Academic Recruitment
Thursday, April 6, 11am EST (Montreal time)
Daniel C. Brennan
Daniel C. Brennan - Biography:
Daniel C. Brennan, MD, FACP, is the Alan A. and Edith L. Wolff Professor of Renal Diseases and the Director of Transplant Nephrology at Washington University School of Medicine in St. Louis, Missouri. Dr. Brennan’s research interests are viral infections, induction immunosuppression therapy, pharmacoeconomic and outcome research in transplantation and islet transplantation. He has written more than 200 original publications and several textbooks in these areas.
Larry Melton - Biography:
Dr. Melton is the Medical Director of Organ Transplant at HackensackUMC. He was previously the Medical Director of Kidney/Pancreas transplant at the Simmons Transplant Institute, Baylor University Medical Center in Dallas, TX. His interests are kidney and pancreas transplantation, combined liver/kidney transplantation and kidney function in liver disease. He is board certified in Internal Medicine, Nephrology and Critical Care Medicine. He attended Baylor University followed by graduate work at the University of Texas Health Science Center in Dallas where he earned a PhD in physiology. He went to medical school at the University of Texas Medical School in San Antonio and did his internship at Parkland Memorial Hospital in Dallas. He then moved to Boston, MA where he did his nephrology and transplant training at the Beth Israel Hospital and remained on the faculty at Harvard Medical School for a year after completion of his training. Following that, Dr. Melton took a position in Dallas where he worked with the transplant program at Baylor University Medical Center and was a senior partner and treasurer of Dallas Nephrology Associates. While in Dallas, he was also a Professor of Internal Medicine at Texas A&M Medical School. He was President of the Texas Transplantation Society and is active in the American Society of Transplantation. He has served on the Board of Directors for the AST, as Chair of the Transplant Accreditation Committee, as well as several other committees including the Public Policy Committee. Dr. Melton testified before Congress for the AST in support of eliminating the 36 month limit on immunosuppressive medication coverage. He has participated in multiple clinical research trials, has authored many papers and book chapters and served as the Co-Scientific Editor of Dialysis and Transplantation.